BioCentury | May 4, 2016
Financial News

MVM closes fourth fund at $233M

...healthcare IT plays. It has invested in pain company Cara Therapeutics Inc. (NASDAQ:CARA), osteoporosis company Tarsa Therapeutics...
BioCentury | Nov 9, 2015
Clinical News

Oral salmon calcitonin regulatory update

...May 27, 2013). Enteris BioPharma Inc. , Boonton, N.J. Tarsa Therapeutics Inc. , Philadelphia, Pa. Product: Oral salmon calcitonin...
BioCentury | Sep 1, 2014
Financial News

Tarsa Therapeutics financial update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date announced: 2014-08-13 Note: Tarsa secured a $10 million senior credit facility from Oxford Finance and Square 1 Bank. WIR Staff Musculoskeletal...
BioCentury | Dec 19, 2013
Cover Story

Oral nanoparticles

...In 2011, Emisphere and partners Nordic Bioscience A/S and Novartis AG discontinued development of the oral salmon calcitonin...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Oct 22, 2012
Clinical News

Oral salmon calcitonin: Phase II data

...of the appeal. Tarsa Therapeutics Inc. , Philadelphia, Pa. Unigene Laboratories Inc. (OTCBB:UGNE), Boonton, N.J. Product: Oral salmon calcitonin...
BioCentury | Aug 20, 2012
Company News

Unigene musculoskeletal news

...see BioCentury, June 11 & Aug. 13). Unigene's Ostora oral recombinant salmon calcitonin, to which Tarsa Therapeutics...
BioCentury | Apr 30, 2012
Finance

Foreseeing liquidity

...few years," he said. Investments include Intarcia Therapeutics Inc. ; Puma Biotechnology Inc . (OTCBB:PBYI); Tarsa Therapeutics...
BioCentury | Mar 19, 2012
Company News

Tarsa Therapeutics board of directors update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Appointed: James Tananbaum, CEO of Foresite Capital WIR Staff Musculoskeletal...
BioCentury | Mar 19, 2012
Financial News

Tarsa Therapeutics completes venture financing

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date completed: 3/16/12 Type: Venture financing Raised: $28 million Investors: Foresite Capital; Novo A/S; MVM Life Science Partners; Quaker Partners WIR Staff Musculoskeletal...
Items per page:
1 - 10 of 76